Skip to content

CA Final · Financial Reporting · Classification and Measurement of Financial Assets and Financial Liabilities

Kaveri Pharma Ltd acquired a business and recognised contingent consideration payable in cash, depending on future EBITDA of the acquiree, as a liability under Ind AS 103. At the next reporting date the liability's fair value rises from ₹40 lakh to ₹52 lakh because of better-than-expected performance. What is the correct treatment under Ind AS 109?

Kaveri should recognise the ₹12 lakh increase (₹52 lakh less ₹40 lakh) as a loss in profit or loss. Contingent consideration recognised by an acquirer in a business combination is subsequently measured at fair value, with changes recognised in profit or loss, not in goodwill or OCI.

  1. AAdd ₹12 lakh to goodwill as a measurement-period adjustment
  2. BRecognise ₹12 lakh as a loss in profit or lossCorrect
  3. CRecognise ₹12 lakh in other comprehensive income
  4. DContinue to carry the liability at ₹40 lakh at amortised cost

Explanation

Para 4.2.1(e) says contingent consideration recognised by an acquirer in a business combination under Ind AS 103 is subsequently measured at fair value, with changes recognised in profit or loss. The increase of ₹52 lakh − ₹40 lakh = ₹12 lakh is therefore a loss. Adjusting goodwill is wrong, as the change arises from post-acquisition events.

Did you get it right without looking?

One question tells you little. A timed set on Classification and Measurement of Financial Assets and Financial Liabilities shows your real accuracy, how long you take and where you lose marks.

More Classification and Measurement of Financial Assets and Financial Liabilities questions